Sirnaomics Ltd.

16/04/2024 | Press release | Distributed by Public on 16/04/2024 14:29

VOLUNTARY ANNOUNCEMENT - SIRNAOMICS RECEIVED FDA SPECIFIC GUIDANCE FOR FURTHER DEVELOPMENT OF STP705 FOR TREATMENT OF SQUAMOUS CELL CARCINOMA IN SITU